An important component “glyphosate” of week killer does not show a significant increase in cancer among the population.
A study has found no link between the glyphosate and cancers. The assessment is based on the Agricultural Health Study focusing the cancers and associated health outcomes on human beings.
A study published in the Journal of the National Cancer Institute (JNCI) found that the Monsanto’s popular herbicide “Roundup” has no association with the tumor formation.
It involved the collaboration between researchers from the National Institute of Environmental Health Sciences, the Environmental Protection Agency (EPA), National Cancer Institute, and National Institute for Occupational Safety and Health.
The glyphosate is potentially used as an herbicide on crop plants like cotton, sugar beet crop, soybean, and other genetically engineered plants to prevent the weed growth.
More than 54,000 pesticide applications were taken into account during studying the effects of glyphosate. Among these applied pesticides, 83 percent contained glyphosate.
The participants included thousands of farmers and their families in Lowa and North Carolina. The Agricultural Health Study (AHS) has carefully analyzed the gathered information related to weed killer and the participants.
“Some evidence increased the risk of acute myeloid leukemia (AML) among groups which were highly exposed to given compound,” according to Reuters but here the significant level of exposure makes a difference.
The correlation between the glyphosate and acute myeloid leukemia (AML) was not found statistically significant to cause harm.
Traces of this weed killer were also found in the 45 percent of European soil, particularly in top layer soil.
In the United Kingdom, 60 percent of grain products contained the glyphosate whereas, three-quarters of Germans participants contained it in their urine.
The findings of the study may influence the decision regarding relicensing of glyphosate across the European Union. Whereas earlier this year many people signed a petition against the application of the glyphosate.
Other environmental organizations and campaigners like Green Peace are also calling for the pesticide to be banned outright. Their stance is based on the WHO’s study.
The World Health Organization’s International Agency for Research on Cancer reviewed the glyphosate in 2015 and classified it as carcinogenic to humans.
Furthermore, according to European Food Safety Authority and European Chemicals Agency glyphosate has no associated carcinogenic effects and is safer to use.
As the summary of results was presented, the Laura Beane Freeman, principal investigator of the study told that total of 54,251 pesticide applicators was studied and 44,932 of them used glyphosate, which makes 82.9 percent of the total.
Scott Partridge, Monsanto’s Vice president of Strategy told Reuters that over the longest period of time, it is the largest study of agriculture workers which demonstrated that glyphosate is not associated with cancers.
“The study clearly stated that weed killer glyphosate was safer to use” he added.
The European Union license to reauthorize the glyphosate was delayed this week because the majority didn’t vote in its favor.
In a conference “Shaping the Vision for Ireland’s Agri-Food Industry 2030”, held at Convention Centre Dubai, Allen said that farmers are totally dependent on a roundup. They need support and help to move forward without using glyphosate.
RELATED: Vitamin C and antibiotic can be more effective in treating cancers- research says
Lucinda Creighton, Former Minister of European Affairs and Deputy Foreign Minister warned the ban of glyphosate as weed killer especially for the development of Irish farmer community.
There is uncertainty regarding uses and risks of glyphosate but despite all evidence against the disruption caused by herbicide, glyphosate is registered in 100 countries.
The decision of European Union whether to ban glyphosate or not could speculate on the data obtained from the AHS or not due to increased pressure from other groups.